MAIA Biotechnology, Inc.
MAIA
$2.55
$0.21018.98%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.95M | 7.57M | 8.41M | 8.71M | 9.07M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.96M | 18.33M | 19.10M | 19.95M | 20.18M |
| Operating Income | -16.96M | -18.33M | -19.10M | -19.95M | -20.18M |
| Income Before Tax | -23.25M | -25.94M | -28.08M | -23.72M | -19.77M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -23.25 | -25.94 | -28.08 | -23.72 | -19.77 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.25M | -25.94M | -28.08M | -23.72M | -19.77M |
| EBIT | -16.96M | -18.33M | -19.10M | -19.95M | -20.18M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -1.12 | -1.38 | -1.62 | -1.57 | -1.49 |
| Normalized Basic EPS | -0.70 | -0.86 | -1.01 | -0.98 | -0.93 |
| EPS Diluted | -1.12 | -1.38 | -1.62 | -1.57 | -1.49 |
| Normalized Diluted EPS | -0.70 | -0.86 | -1.01 | -0.98 | -0.93 |
| Average Basic Shares Outstanding | 88.74M | 79.18M | 68.96M | 59.64M | 53.02M |
| Average Diluted Shares Outstanding | 88.74M | 79.18M | 68.96M | 59.64M | 53.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |